Investigadores del grupo de enfermedades neurodegenerativas de IDIVAL y del CSUR de ataxias y paraplejías hereditarias del HUMV participan en un estudio multicéntrico europeo diseñado para la ident...
Read more
Result show that adding immune checkpoint inhibitor atezolizumab to standard of care with bevacizumab and chemotherapy significantly improves progression-free survival and overall survival in patients...
Read more
They informed to the AEMPS of the EARLY CLOSURE of the ICD-01 Phase III clinical trial, having reached significant statistical results before completing recruitment, during the second interim analysis...
Read more
This pioneering test aids oncologists in predicting recurrence and survival rates in breast cancer patients and potential treatment eligibility to bisphosphonates
Read more
The project RECOMB, in which Vall d'Hebron participates, has recently launched a clinical trial to develop a gene therapy to cure patients with SCID, popularly known as "bubble child syndrome" who hav...
Read more
El virus de Marburgo, de la misma familia que el virus Ébola, es un patógeno con una alta tasa de mortalidad para cuya infección no existen tratamientos eficaces ni vacunas
Read more
ICH E9 and CDISC share the goal of improving the quality and efficiency of clinical research and medicinal product development. Although they focus on different aspects of clinical data management, th...
Read more
Han puesto en marcha un ensayo clínico para evaluar la seguridad y la eficacia de esta nueva inmunoterapia celular adoptiva, propiedad del Hospital Clínic de Barcelona, el IDIBAPS y la UB, en pacien...
Read more
A clinical trial carried out by Hospital del Mar, Pompeu Fabra University, the Health Research Institute of Santiago de Compostela and the Pere Virgili Health Park investigated the efficacy and safety...
Read more
El premio se realiza en plena ronda de inversión que Laminar ha abierto hasta el 5 de febrero, momento en el que se espera recibir poco después el resultado del análisis intermedio del ensayo clín...
Read more
Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, today announced topline results from the Pha...
Read more
Un ensayo con más de 30 000 participantes aporta datos de eficacia y seguridad para la vacuna de ARN mensajero frente al virus respiratorio sincitial desarrollada por Moderna. Los datos se publican e...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
